Spain Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Spanish pharmaceuticals market had total revenues of $26.5 billion in 2022, representing a compound annual growth rate (CAGR) of 14.3% between 2017 and 2022.
0
According to in-house research, in 2022, Spain accounted for 7.5% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Spain stood at 14.6% of total health spending in 2021.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Spain
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
What was the size of the Spain pharmaceuticals market by value in 2022?
What will be the size of the Spain pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Spain pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Spain's pharmaceuticals market?